We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

New Blood Test Predicts Sepsis in Burn Patients

By HospiMedica International staff writers
Posted on 20 Jul 2016
A new study suggests that measuring three biomarkers of neutrophil function could help determine which burn victims are likely to develop sepsis during their treatment.

Researchers at the University of Birmingham (UB; United Kingdom) and Queen Elizabeth Hospital Birmingham (QEHB; United Kingdom), conducted a study in 62 patients admitted to the QEHB Burns Centre with 39% burns (on average), who were recruited within 24 hours of their injury. More...
The researchers measured peripheral blood neutrophil function and biomarkers of neutrophil phagocytosis, oxidative burst capacity, and neutrophil extracellular trap (NET). The patients where then monitored in the weeks following for development of sepsis.

In addition, three potential biomarkers of sepsis were tracked - immature granulocyte (IG) count, plasma citrullinated histone H3 (Cit H3), and plasma cell-free DNA (cfDNA). The researchers found that neutrophil function was reduced in a greater degree in patients who developed sepsis, which was also characterized by elevated IG, Plasma cfDNA, and Cit-H3 during septic episodes. The researchers concluded that measurement of the three markers at the first post-injury day gave good discriminatory power for the identifying potentially septic patients. The study was published on May 26, 2016, in Annals of Surgery.

“The researchers have shown that burn patients who may suffer life threatening systemic infections, which occur in 30% of major burns at around day six following their injury, could be identified with a 98.6% certainty,” said study co-author Mr Naiem Moiemen, burns and plastics consultant at QEHB. “Burn patients who suffer systemic infection have a high probability of non-surviving their injury. This discovery will enable the clinicians to stratify the care of these patients and improve their outcomes.”

“Major burn injuries result in a systemic inflammatory response syndrome (SIRS) and reduced immune function, which increases the risk of patients developing sepsis or infections in hospitals. Administration of antibiotics within three hours after sepsis recognition is recommended, but only when positive blood cultures are present,” said senior author Professor Janet Lord, PhD, director of the UB institute of inflammation and ageing. “However, the majority of clinical studies report negative cultures in as many as 40% of severe sepsis patients, so many cases will be missed. As such, the identification of novel, accurate biomarkers is crucial.”

Neutrophils are the most abundant (40-75 %) type of white blood cells (WBCs) in mammals, and form an essential part of the innate immune system. Normally found in the bloodstream, they are short-lived and highly motile, recruited to the site of an injury by chemotaxis within minutes following trauma. They are also the predominant cells in pus, accounting for its whitish/yellowish appearance.

Related Links:
University of Birmingham
Queen Elizabeth Hospital Birmingham

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.